Literature DB >> 32702518

Improving evaluation of drugs in atopic dermatitis by combining clinical and molecular measures.

Jacob W Glickman1, Joseph Han1, Sandra Garcet2, James G Krueger2, Ana B Pavel3, Emma Guttman-Yassky4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32702518     DOI： 10.1016/j.jaip.2020.07.015

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


× No keyword cloud information.
  4 in total

1.  Cytokine RNA In Situ Hybridization Permits Individualized Molecular Phenotyping in Biopsies of Psoriasis and Atopic Dermatitis.

Authors:  Alice Wang; Alexander L Fogel; Michael J Murphy; Gauri Panse; Meaghan K McGeary; Jennifer M McNiff; Marcus Bosenberg; Matthew D Vesely; Jeffrey M Cohen; Christine J Ko; Brett A King; William Damsky
Journal:  JID Innov       Date:  2021-05-07

2.  Pharmacokinetics, Safety, Efficacy, and Biomarker Profiles During Nemolizumab Treatment of Atopic Dermatitis in Adolescents.

Authors:  Robert Sidbury; Sady Alpizar; Vivian Laquer; Sunil Dhawan; William Abramovits; Luca Loprete; Jayendar Kumar Krishnaswamy; Faiz Ahmad; Zarif Jabbar-Lopez; Christophe Piketty
Journal:  Dermatol Ther (Heidelb)       Date:  2022-01-28

Review 3.  Atopic Dermatitis: Striving for Reliable Biomarkers.

Authors:  Styliani Mastraftsi; Georgia Vrioni; Michail Bakakis; Electra Nicolaidou; Dimitrios Rigopoulos; Alexander J Stratigos; Stamatios Gregoriou
Journal:  J Clin Med       Date:  2022-08-09       Impact factor: 4.964

Review 4.  Biologics for Treatment of Atopic Dermatitis: Current Status and Future Prospect.

Authors:  Thanaporn Ratchataswan; Tina M Banzon; Jacob P Thyssen; Stephan Weidinger; Emma Guttman-Yassky; Wanda Phipatanakul
Journal:  J Allergy Clin Immunol Pract       Date:  2021-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.